Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Covington
Dow
Fuji
Fish and Richardson
Cerilliant
Novartis
Colorcon
Queensland Health

Generated: August 23, 2017

DrugPatentWatch Database Preview

TAGRISSO Drug Profile

« Back to Dashboard

What is the patent landscape for Tagrisso, and what generic Tagrisso alternatives are available?

Tagrisso is a drug marketed by Astrazeneca Pharms and is included in one NDA. There is one patent protecting this drug.

This drug has sixty-nine patent family members in thirty-three countries.

The generic ingredient in TAGRISSO is osimertinib mesylate. One supplier is listed for this compound. Additional details are available on the osimertinib mesylate profile page.

Summary for Tradename: TAGRISSO

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list40
Clinical Trials: see list13
Patent Applications: see list2
Drug Prices:see details
DailyMed Link:TAGRISSO at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca Pharms
TAGRISSO
osimertinib mesylate
TABLET;ORAL208065-001Nov 13, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Astrazeneca Pharms
TAGRISSO
osimertinib mesylate
TABLET;ORAL208065-002Nov 13, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
Astrazeneca Pharms
TAGRISSO
osimertinib mesylate
TABLET;ORAL208065-001Nov 13, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Astrazeneca Pharms
TAGRISSO
osimertinib mesylate
TABLET;ORAL208065-001Nov 13, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Astrazeneca Pharms
TAGRISSO
osimertinib mesylate
TABLET;ORAL208065-002Nov 13, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Astrazeneca Pharms
TAGRISSO
osimertinib mesylate
TABLET;ORAL208065-002Nov 13, 2015RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TAGRISSO

Country Document Number Estimated Expiration
South Korea101410902► Subscribe
Serbia54653► Subscribe
Israel242279► Subscribe
Israel242278► Subscribe
Japan2014139226► Subscribe
Dominican RepublicP2013000263► Subscribe
South Korea101691268► Subscribe
South Korea20140062181► Subscribe
South Korea20140030089► Subscribe
Ukraine106710► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Novartis
Citi
Julphar
Cantor Fitzgerald
QuintilesIMS
Baxter
Fish and Richardson
Cipla
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot